Skip to main content

sec filings

Insider trades

Open-market buys and sales that company insiders report to the SEC on .

Side
Planned sales
Role
RLAY

Updated 10/6/2026, 8:11 AM ET.

RLAY

Relay Therapeutics, Inc.

Sale$161,814

Bergstrom Donald A

President, R&D

8,530 shat $18.97Filed Sep 9, 4:17 PM ET
Filing
RLAY

Relay Therapeutics, Inc.

Sale$335,560

Catinazzo Thomas

Chief Financial Officer

17,717 shat $18.94Filed Sep 9, 4:15 PM ET
Filing
RLAY

Relay Therapeutics, Inc.

Sale$912,889

Patel Sanjiv

President and CEO, Director

48,199 shat $18.94Filed Sep 9, 4:12 PM ET
Filing
RLAY

Relay Therapeutics, Inc.

Sale$90,295

Rahmer Peter

See remarks

4,508 shat $20.03Filed Aug 28, 4:43 PM ET
Filing
RLAY

Relay Therapeutics, Inc.

Sale$116,400,000

SVF Pauling (Cayman) Ltd

10% owner

and 2 others

6,000,000 shat $19.40Filed Aug 28, 9:01 AM ETFiling
RLAY

Relay Therapeutics, Inc.

Sale$979,886

Patel Sanjiv

President and CEO, Director

48,199 shat $20.33Filed Aug 18, 4:17 PM ET
Filing
RLAY

Relay Therapeutics, Inc.

Sale$349,734

Catinazzo Thomas

Chief Financial Officer

17,717 shat $19.74Filed Aug 18, 4:16 PM ET
Filing
RLAY

Relay Therapeutics, Inc.

Sale$27,152

Catinazzo Thomas

Chief Financial Officer

1,459 shat $18.61Filed Jul 30, 4:13 PM ETFiling
RLAY

Relay Therapeutics, Inc.

Sale$13,920

Rahmer Peter

See remarks

748 shat $18.61Filed Jul 30, 4:13 PM ETFiling
RLAY

Relay Therapeutics, Inc.

Sale$41,631

Bergstrom Donald A

President, R&D

2,237 shat $18.61Filed Jul 30, 4:12 PM ETFiling
RLAY

Relay Therapeutics, Inc.

Sale$162,029

Bergstrom Donald A

President, R&D

8,660 shat $18.71Filed Jul 8, 5:11 PM ET
Filing
RLAY

Relay Therapeutics, Inc.

Sale$943,736

Patel Sanjiv

President and CEO, Director

48,199 shat $19.58Filed Jul 8, 5:08 PM ET
Filing
RLAY

Relay Therapeutics, Inc.

Sale$331,131

Catinazzo Thomas

Chief Financial Officer

17,717 shat $18.69Filed Jul 8, 5:07 PM ET
Filing

Read from public SEC filings. Not financial advice.